<DOC>
	<DOCNO>NCT02413892</DOCNO>
	<brief_summary>Echinocandins drug choice severe candida infection . Efficacy echinocandins related concentration area curve ( AUC ) drug . Available pharmacokinetic study find concentration echinocandins mainly caspofungin sub-optimal severe candida infection intensive care unit ( ICU ) patient . Higher dose caspofungin proven safe critically ill patient impact ability reach PK/PD target unknown . The aim study evaluate impact load dose caspofungin PK/PD parameter within first 24-hours .</brief_summary>
	<brief_title>Impact Loading Dose Caspofungin Invasive Candidiasis ICU Patients</brief_title>
	<detailed_description>Invasive fungal infection associate high mortality rate ICU , partly delay treatment . PK/PD target caspofungin peak concentration minimal inhibitory concentration ( MIC ) ratio reach 10 area inhibitory curve ( AUIC ) 200 . High distribution volume ICU patient increase MICs due extensive use antifungal agent make optimal concentration difficult obtain . High dose 150mg caspofungin report safe . Thus , unit , load dose 140mg caspofungin standard practice never rigorously evaluate . The aim present study measure impact load dose 140mg caspofungin pharmacokinetic parameter first 24 hour treatment . The AUIC maximal concentration ( CMax ) / ( MIC ) accord recovered yeast measure . The investigator also plan Monte-Carlo simulation use MICs obtain clinically relevant candida strain isolate Bichat Grenoble hospital order evaluate percentage patient appropriately treat within first 24 hour accord Candida specie previous use antifungal . Recovered strain epidemiological study use PKPD model use s. A second Monte-Carlo simulation do use data Amarcand 2 study . All MICs determine use E-test ( BiomerieuxÂ® KIT 's ) without specify breakpoints MICs breakpoints per se use .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<criteria>Patient hospitalize intensive care Age &gt; 18 year Patient central catheter Patient invasive mechanical ventilation Patient receive 0.1 mcg / kg / min adrenaline noradrenaline Patient treat proven ( positive blood culture positive specimen obtain surgical percutaneous puncture ) suspect ( risk factor , extra digestive colonization , absence uncontrolled bacterial infection , candida score &gt; 3 ) invasive candidiasis . Patient affiliate medical insurance Expected length stay 48H Age &lt; 18 year Pregnant breastfeed woman Limited sustained life support therapy Patient unable legally consent History Allergy , hypersensitivity intolerance echinocandins Drug excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>